Jones Trading Maintains Buy on Alto Neuroscience, Lowers Price Target to $44

Benzinga Newsdesk www.benzinga.com Negative 65.2%

Neg 65.2% Neu 0% Pos 0%

Jones Trading analyst Justin Walsh maintains Alto Neuroscience (NYSE:ANRO) with a Buy and lowers the price target from $49 to $44.